MARKET

PDSB

PDSB

Pds Biotechnology Corporation
NASDAQ
5.93
+0.39
+7.04%
Opening 13:39 02/27 EST
OPEN
5.70
PREV CLOSE
5.54
HIGH
6.19
LOW
5.69
VOLUME
1.28M
TURNOVER
0
52 WEEK HIGH
10.27
52 WEEK LOW
3.800
MARKET CAP
184.47M
P/E (TTM)
-3.4839
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at PDSB last week (0219-0223)?
Weekly Report · 1d ago
Weekly Report: what happened at PDSB last week (0212-0216)?
Weekly Report · 02/19 10:20
Weekly Report: what happened at PDSB last week (0205-0209)?
Weekly Report · 02/12 10:14
Weekly Report: what happened at PDSB last week (0129-0202)?
Weekly Report · 02/05 10:19
Weekly Report: what happened at PDSB last week (0122-0126)?
Weekly Report · 01/29 10:13
PDS Biotechnology: Advancement Of PDS0101 Continues With Expansion Data
Seeking Alpha · 01/26 23:59
Pds Biotechnology Corporation: Initial statement of beneficial ownership of securities
Press release · 01/23 22:24
Pds Biotechnology Corporation: Statement of changes in beneficial ownership of securities
Press release · 01/23 22:24
More
About PDSB
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted immunotherapies for cancer and infectious diseases based on its Versamune, Versamune plus PDS0301, and Infectimune T cell-activating platforms. Its lead clinical candidate, PDS0101, is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. PDS0101, has demonstrated the ability to reduce tumors and stabilize disease in combination with approved and investigational therapeutics in patients with a range of HPV16-associated cancers. PDS0301 is an investigational tumor-targeting antibody conjugate of Interleukin 12 (IL-12) that enhances the proliferation, potency, infiltration and longevity of T cells in the tumor microenvironment. PDS0102, PDS0103, PDS0104, PDS0201, PDS0202, and PDS0203 are also in its pipeline of Versamune and Infectimune-based therapies.

Webull offers PDS Biotechnology Corp stock information, including NASDAQ: PDSB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDSB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDSB stock methods without spending real money on the virtual paper trading platform.